fda_483 · inspection_citation · high

Baxter Oncology GmbH -- FDA 483: 1 observation (2025-09-26)

Event date
2025-09-26 00:00:00Z
Observed
2026-07-12 22:31:34Z
Source ID
3002806419-2025-09-26-190881
Payload hash
b8a4776b670ca46874517b6b

Summary

Observation 2: Procedures designed to prevent microbiological contamination of dmg products purp01ting to be sterile are not established and fo llowed. 4 1. Aseptic behavior procedure SOP-01007, which...

Informational only. Not legal, financial, or medical advice.